Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Teva Branded Pharmaceutical Products R&D, Inc.
Age
4–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Persistent asthma for a minimum of six months duration that has been stable for at least four weeks
Predicted FEV1 60-90%
Demonstration of 12% airway reversibility
You may not be if
Continuous requirement for beta-blockers, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, anticholinergics and/or steroids other than those inhaled;
Presence of clinically-significant non-asthmatic acute or chronic disease
Clareo Health | Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
